Misplaced Pages

The following pages link to Template:Targeted cancer therapeutic agents

• (link count
• transclusion count
• sorted list) · See help page for transcluding these entries

Showing 50 items.

• Chemotherapy (transclusion) (links | edit)
• Sirolimus (transclusion) (links | edit)
• Everolimus (transclusion) (links | edit)
• Imatinib (transclusion) (links | edit)
• Trastuzumab (transclusion) (links | edit)
• ATC code L (transclusion) (links | edit)
• ATC code L01 (transclusion) (links | edit)
• Gefitinib (transclusion) (links | edit)
• Rituximab (transclusion) (links | edit)
• Bevacizumab (transclusion) (links | edit)
• Cetuximab (transclusion) (links | edit)
• Erlotinib (transclusion) (links | edit)
• Ibritumomab tiuxetan (transclusion) (links | edit)
• Alemtuzumab (transclusion) (links | edit)
• Gemtuzumab ozogamicin (transclusion) (links | edit)
• Targeted therapy (transclusion) (links | edit)
• Sorafenib (transclusion) (links | edit)
• Sunitinib (transclusion) (links | edit)
• Lapatinib (transclusion) (links | edit)
• Nilotinib (transclusion) (links | edit)
• Dasatinib (transclusion) (links | edit)
• Denileukin diftitox (transclusion) (links | edit)
• Tositumomab (transclusion) (links | edit)
• Monoclonal antibody therapy (transclusion) (links | edit)
• Panitumumab (transclusion) (links | edit)
• Vandetanib (transclusion) (links | edit)
• Edrecolomab (transclusion) (links | edit)
• Pertuzumab (transclusion) (links | edit)
• Catumaxomab (transclusion) (links | edit)
• Ipilimumab (transclusion) (links | edit)
• Tremelimumab (transclusion) (links | edit)
• Inotuzumab ozogamicin (transclusion) (links | edit)
• Ofatumumab (transclusion) (links | edit)
• Semaxanib (transclusion) (links | edit)
• Protein kinase inhibitor (transclusion) (links | edit)
• Cediranib (transclusion) (links | edit)
• Pazopanib (transclusion) (links | edit)
• Temsirolimus (transclusion) (links | edit)
• Axitinib (transclusion) (links | edit)
• Ridaforolimus (transclusion) (links | edit)
• Lestaurtinib (transclusion) (links | edit)
• Bosutinib (transclusion) (links | edit)
• Aflibercept (transclusion) (links | edit)
• Elotuzumab (transclusion) (links | edit)
• Blinatumomab (transclusion) (links | edit)
• Afatinib (transclusion) (links | edit)
• Ramucirumab (transclusion) (links | edit)
• Obinutuzumab (transclusion) (links | edit)
• Neratinib (transclusion) (links | edit)
• Necitumumab (transclusion) (links | edit)